NIH HEAL INITIATIVE

NIH HEAL INITIATIVE

In April 2018, NIH launched the HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. This Initiative will build on extensive, well-established NIH research, including basic science of the complex neurological pathways involved in pain and addiction, implementation science to develop and test treatment models, and research to integrate behavioral interventions with Medication-Assisted Treatment (MAT) for opioid use disorder (OUD). Successes from this research include the development of the nasal form of naloxone, the most commonly used nasal spray for reversing opioid overdose, the development of buprenorphine for the treatment of opioid use disorder, and evidence for the use of nondrug and mind/body techniques such as yoga, tai chi, acupuncture, and mindfulness meditation to help patients control and manage pain.

Over the past year, NIH has worked with experts from public and private organizations to identify the areas that would benefit from focused efforts by NIH alone or in partnerships with outside organizations.

The NIH HEAL Initiative will bolster research across NIH to:

  • Prevent Addiction through Enhanced Pain Management
    More than 25 million Americans suffer from daily chronic pain. NIH will support research to understand how chronic pain develops, making patients susceptible to risks associated with opioid use. NIH will work with partners from the biopharmaceutical industry to develop a data sharing collaborative, new biomarkers for pain, and a clinical trials network for testing new pain therapies. NIH will also enhance the pipeline of treatments for pain and enhance clinical practice for pain management.
  • Improve Treatments for Opioid Misuse Disorder and Addiction
    More than 2 million Americans have OUD. Millions more misuse opioids, taking opioid medications longer or in higher doses than prescribed. NIH will support research that can prevent and treat opioid misuse and addiction, and that will help people with OUDs achieve and maintain a meaningful and sustained recovery.

For more than 60 years, LICADD has successfully delivered evidence-based programs designed to prevent and treat substance abuse and addiction. LICADD offers crisis intervention, screenings, brief interventions, referrals to treatment and several family and parent education workshops to help Long Islanders struggling with the effects of addiction. Through our Open Arms, EAP Program, LICADD has provided targeted solution-focused support to companies all along the East Coast, serving over 60,000 employees and their families.

LICADD is Long Island’s premier non-profit agency providing life-saving alcohol and drug prevention and intervention services to at-risk children, individuals, and families across the region. With offices in Mineola, Holbrook and Riverhead, LICADD conducts evidence-based prevention programs, community outreach initiatives, and a mentoring program for children of incarcerated parents and public policy advocacy.

For more information please call (516) 747-2606 or visit us on the web at www.licadd.org and Facebook and Instagram.

# # #

CONTACT: Christopher Kelly
Development & Communications Associate
516-747-2606 ckelly@licadd.org

  • 2
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2
  •  
  •  
  •  
  •  
  •  
  •  
  •